𝔖 Bobbio Scriptorium
✦   LIBER   ✦

725 SEQUENTIAL USE OF MTOR -INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): SAFETY AND EFFICACY FOLLOWING FAILURE OF RECEPTOR TYROSINE KINASE INHIBITOR (TKI) TREATMENT

✍ Scribed by J. Busch; C. Kempkensteffen; V. Grünwald; L. Weinkauf; S. Hinz; A. Magheli; K. Miller; M. Johannsen; S. Weikert


Book ID
119623064
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
176 KB
Volume
10
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES